Safety and efficacy of topically administered netarsudil (Rhopressa™) in normal and glaucomatous dogs with ADAMTS10-open-angle glaucoma (ADAMTS10-OAG)

Documenti analoghi

• A Novel Missense Mutation in ADAMTS10 in Norwegian Elkhound Primary Glaucoma
  di: Ahonen, Saija J., et al.
  Pubblicazione: (2014)
• Influence of Age on Ocular Biomechanical Properties in a Canine Glaucoma Model with ADAMTS10 Mutation
  di: Palko, Joel R., et al.
  Pubblicazione: (2016)
• Netarsudil-Induced Corneal Flattening in a Child with Secondary Open-Angle Glaucoma
  di: Durga Ganesh, et al.
  Pubblicazione: (2022-05-01)
• Profile of netarsudil ophthalmic solution and its potential in the treatment of open-angle glaucoma: evidence to date
  di: Dasso, Lily, et al.
  Pubblicazione: (2018)
• A Novel Genome-Wide Association Study Approach Using Genotyping by Exome Sequencing Leads to the Identification of a Primary Open Angle Glaucoma Associated Inversion Disrupting ADAMTS17
  di: Forman, Oliver P., et al.
  Pubblicazione: (2015)